dexmedetomidine hydrochloride - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
DEXMEDETOMIDINE VIATRIS dexmedetomidine (as hydrochloride) 200 microgram/2 mL concentrated injection vial AUST R: 271410Active ingredients:
dexmedetomidine hydrochloride
Dosage form:
Injection, concentrated
Sponsor:
Alphapharm Pty Ltd
Phone:
1800274276
|
From
30 Aug 2023
to
27 Feb 2024
|
Shortage status:
Resolved
Availability:
Available
Reason:
Unexpected increase in consumer demand
|
PRECEDEX READY TO USE dexmedetomidine hydrochloride 80 micrograms/20 mL injection for intravenous infusion vial AUST R: 234022Active ingredients:
dexmedetomidine hydrochloride
Dosage form:
Injection, intravenous infusion
Sponsor:
Pfizer Australia Pty Ltd
Phone:
1800-675-229
|
Deletion from market:
29 Feb 2024
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
|